Future Market Insights12m
Global Fatty Liver Treatment Market Expected to Reach USD 32.5 Billion by 2032 develop at a CAGR of 5%
The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...
Le Lézard48m
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One of several biosimilar value drivers for SandozSandoz ...